echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature Biotechnology: New CRISPR-Cas methods lead to more precise DNA cutting

    Nature Biotechnology: New CRISPR-Cas methods lead to more precise DNA cutting

    • Last Update: 2022-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    A team led by researchers at Massachusetts General Hospital (MGH) has overcome major limitations
    in cutting and editing DNA through the CRISPR-Cas enzyme and other technologies.
    The recent innovation, published in the journal Nature Biotechnology, will simplify and accelerate molecular cloning methods and expand their usefulness

    CRISPR-Cas editing has changed researchers' ability to alter DNA — for example, cutting specific DNA sequences in ways that restriction enzymes or proteins isolated from bacteria cannot, and this protein has been used to cut DNA sequences at specific sites for decades
    Although the CRISPR-Cas tool can be programmed to locate and cut almost any DNA sequence, a major limitation of its localization is the requirement to first identify short sequences located on the flank of the target, called the proto-spaced adjacent motif (PAM).

    As a result, DNA could previously only be cut
    on the side of this particular motif.

    In this latest study, the team previously designed a variant of CRISPR-Cas9 with almost no PAM, called SpRY, to test its utility as a universal DNA-cutting tool

    By designing the SpRY and guide RNA (gRNA) complexes to target more than 130 DNA sequences in laboratory experiments, the scientists were surprised to find that SpRY was PAMless-free in vitro and could efficiently cut DNA
    from any sequence programmed by gRNA.
    The researchers also showed that their technique can overcome the limitations
    of restriction enzymes.

    "We demonstrated that SpRY DNA digestion (sprygests) enables DNA cutting in almost any sequence, including a wide range, that could not previously be targeted with restriction enzymes or other CRISPR-Cas proteins," said senior author Benjamin Kleinstver, Ph.
    , a research assistant at the Center for Genomic Medicine at Massachusetts General Hospital and an assistant professor
    at Harvard Medical School.
    This new method allows researchers to select any DNA location in the test tube to cut DNA
    The new capabilities offered by SpRYgests will accelerate and reduce the cost of a variety of basic research applications, including research
    that may ultimately have clinical impact.

    The researchers envision that SpRYgests can be widely used to simplify typical molecular cloning methods, more complex cloning methods, assemble next-generation sequencing libraries, and many others

    The study was conducted by postdoctoral fellow Kathleen A.
    Led by Dr.
    Christie, she vowed never to use restriction enzymes again
    Other co-authors include Jimmy A.
    Guo, Rachel A.
    Silverstein, Roman M.
    Doll, Megumu Mabuchi, Hannah E.
    Stutzman, Jack-Chung Lin, Marlin-yuan, Russell T.
    Walton, Luca Pinello, and G.
    Brett Robb

    This work was supported by the National Institutes of Health and the
    National Science Foundation.


    Precise DNA cleavage using CRISPR-SpRYgests

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.